Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

5,330 companies

Ticker	Company	Revenue	Net income ▾	Net margin	Return on equity	Revenue growth	Diluted EPS
URGN	UroGen Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$109.79M	-$153.49M	-139.8%	n/a	21.4%	n/a
CBIO	Crescent Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.84M	-$153.94M	n/m	-75.8%	n/a	n/a
MLYS	Mineralys Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$154.65M	n/a	-23.9%	n/a	-$2.29
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
ENVX	Enovix Corp Manufacturing · Year ended 2025-12-28 · USD	$31.82M	-$156.74M	-492.6%	-57.8%	37.9%	-$0.75
ETCG	Grayscale Ethereum Classic Trust (ETC) Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	-$157.05M	n/a	n/a	n/a	n/a
GLOO	Gloo Holdings, Inc. Services · Year ended 2026-01-31 · USD	$94.66M	-$157.13M	-166.0%	-101.9%	307.7%	-$8.03
ZNB	Zeta Network Group Services · Year ended 2026-06-30 · USD	$28.36M	-$157.46M	-555.2%	-132.0%	225.0%	-$927.59
AVIR	Atea Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$158.35M	n/a	-57.5%	n/a	-$1.94
MAGN	Magnera Corp Manufacturing · Year ended 2025-09-27 · USD	$3.20B	-$159.00M	-5.0%	-14.9%	46.5%	-$4.47
ASPI	ASP Isotopes Inc. Manufacturing · Year ended 2025-12-31 · USD	$23.85M	-$159.84M	-670.2%	-78.3%	475.5%	-$2.11
TTAN	ServiceTitan, Inc. Services · Year ended 2026-01-31 · USD	$960.97M	-$159.85M	-16.6%	-10.5%	24.5%	-$1.73
EDIT	Editas Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.52M	-$160.06M	-395.0%	-586.6%	25.4%	-$1.80
SMNR	Semnur Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$160.42M	n/a	n/a	n/a	-$0.78
PBF	PBF Energy Inc. Manufacturing · Year ended 2025-12-31 · USD	$29.33B	-$160.50M	-0.5%	-2.9%	-11.4%	-$1.39
CGON	CG Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.04M	-$161.00M	n/m	-21.4%	254.7%	-$2.08
MPLT	MapLight Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$161.15M	n/a	-35.2%	n/a	-$18.56
KYTX	Kyverna Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$161.31M	n/a	-69.4%	n/a	-$3.64
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
OLMA	Olema Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$162.45M	n/a	-33.9%	n/a	-$1.87
CRWD	CrowdStrike Holdings, Inc. Services · Year ended 2026-01-31 · USD	$4.81B	-$162.50M	-3.4%	-3.6%	21.7%	-$0.65
HP	Helmerich & Payne, Inc. Mining · Year ended 2025-09-30 · USD	$3.75B	-$163.69M	-4.4%	-5.8%	35.9%	-$1.66
NKTR	Nektar Therapeutics Manufacturing · Year ended 2025-12-31 · USD	$55.23M	-$164.08M	-297.1%	-182.6%	-43.9%	-$9.73
LMND	Lemonade, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$737.90M	-$165.50M	-22.4%	-31.0%	40.2%	-$2.24
LRMR	Larimar Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$165.67M	n/a	-212.2%	n/a	n/a

Rows per page: 2550 100